The immune cellular composition of amniotic fluid is poorly understood.
| INTRODUC TI ON
Amniotic fluid is the protective liquid that surrounds the fetus throughout gestation and, therefore, is essential for fetal development and maturation. 1 Besides containing nutrients and other factors required for fetal growth, the amniotic fluid provides mechanical cushioning and represents an immunological barrier against invading pathogens. 1,2 The amniotic fluid is used as a diagnostic tool for assessing fetal well-being, [3] [4] [5] [6] [7] lung maturity, [8] [9] [10] [11] karyotype, [12] [13] [14] [15] and intra-amniotic infection and/or inflammation. During early development, the amniotic fluid is an extension of the fetal extracellular matrix. 75 As the placenta and fetal vessels emerge, water and solutes from the maternal plasma diffuse into the amniotic fluid. 76 By 8 weeks of gestation, the urethra is formed and the fetal kidneys start producing urine. 77 Shortly after, fetal swallowing begins; 75 however, these processes do not contribute to the amniotic fluid volume until the second half of pregnancy. 77 After 25 weeks of gestation, the fetal skin is fully keratinized 78 and the amniotic fluid volume is determined by factors comprising the amniotic fluid circulation (fetal urine, respiratory system, gastrointestinal system, umbilical cord, and placenta). 75, [77] [78] [79] [80] The amniotic fluid contains soluble and cellular components. 77 The soluble components include carbohydrates, proteins, peptides, lipids, lactate, pyruvate, electrolytes, enzymes, and hormones, among others, [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] many of which act as the first line of defense against pathogens invading the amniotic cavity. [100] [101] [102] [103] [104] [105] [106] The cellular components of the amniotic fluid include different cell types derived from exfoliating surfaces of the developing fetus, including the skin, respiratory system, urinary tract, and gastrointestinal tract as well as stem cells. [107] [108] [109] [110] [111] [112] [113] [114] [115] Some cytological studies have shown that, in the absence of infection, the amniotic fluid also includes a low number of innate immune cells including macrophages, 110, 111, [116] [117] [118] neutrophils, 23, 69 and the recently described innate lymphoid cells or ILCs. 119 Yet, the number of macrophages and/or ILCs is increased in pathological conditions in which fetal organs are exposed to the amniotic fluid (eg, neural tube defects 118, [120] [121] [122] [123] [124] [125] and gastroschisis 118, [126] [127] [128] ). The number of amniotic fluid neutrophils, on the other hand, is a useful marker for intra-amniotic inflammation. 23, 27, [67] [68] [69] [129] [130] [131] [132] However, in the absence of infection and/or inflammation or birth defects, the immune cellular composition of the amniotic fluid is still poorly understood.
The aims of this study were (i) to determine the immunophe- 
| MATERIAL S AND ME THODS

| Study population
This was a cross-sectional study of patients who underwent transabdominal amniocentesis due to clinical indications or amniocentesis during a cesarean delivery. Patients were enrolled at Hutzel Women's Hospital of the Detroit Medical Center. The first group of patients (n = 57, absence of intra-amniotic infection/inflammation) was selected based on the following exclusion criteria: a positive amniotic fluid culture, 20, 39, 54 a white blood cell (WBC) count >50 cells/mm, 23 a glucose concentration <14 mg/dL, 22 an amniotic fluid interleukin (IL)-6 concentration >2.6 ng/mL, 39 a positive Gram stain, 17 and/or a bacterial live/dead staining, 68 and samples from women with an intrauterine fetal demise and/or birth defects. A second group of patients with intra-amniotic infection/inflammation was also included (n = 9).
Intra-amniotic infection/inflammation was defined as the presence of microbial invasion of the amniotic cavity (MIAC) with intra-amniotic inflammation. 39, 47, 48, [50] [51] [52] [53] [54] [55] [56] All of the samples with visible blood contamination were excluded from this study. 
| Sample collection
Amniotic fluid was retrieved by transabdominal amniocentesis under antiseptic conditions using a 22-gauge needle monitored by ultrasound. Amniotic fluid was also retrieved by amniocentesis during cesarean deliveries under antiseptic conditions. Amniotic fluid samples were transported to the clinical laboratory in a capped sterile syringe and were cultured for aerobic and anaerobic bacteria as well as for genital Mycoplasmas. 20, 23, 39, 54 Shortly after collection, a WBC count in amniotic fluid samples was determined using a hemocytometer chamber, according to methods previously described. 23 Glucose concentration 22 was also determined and a Gram stain 17 was performed in amniotic fluid samples. Cultures, WBC counts, glucose concentrations, and Gram stains were not performed in amniotic fluid samples collected during cesarean section, as these samples were collected for research purposes only. However, both IL-6 concentration 39 and the presence of bacteria (bacterial live/dead stain-
were assessed in all of the amniotic fluid samples.
| Determination of interleukin-6 in the amniotic fluid
IL-6 concentration in the amniotic fluid was determined using a sensitive and specific enzyme immunoassay obtained from R&D Systems (Minneapolis, MN, USA). IL-6 concentration was determined by interpolation from the standard curves. The inter-and intra-assay coefficients of variation for IL-6 were 8.7% and 4.6%, respectively. The detection limit of the IL-6 assay was 0.09 pg/mL.
| Detection of live/dead bacteria in the amniotic fluid
The presence of bacteria in the amniotic fluid (n = 66) was evaluated as 
| Isolation of peripheral blood mononuclear cells
Peripheral blood samples were collected by venipuncture into EDTAcontaining tubes from healthy individuals (n = 3). Peripheral blood mononuclear cells (PBMCs) were isolated using the density gradient reagent Ficoll-Paque Plus (GE Healthcare Life Sciences, Piscataway, NJ, USA) according to the manufacturer's instructions.
| Immunophenotyping
Amniotic fluid samples (5-6 mL; n = 66) were passed through a ster- 
| Statistical Analysis
Statistical analysis was performed using SPSS v19 software (SPSS Inc., IBM Corporation, Armonk, NY, USA). Kruskal-Wallis tests followed by Mann-Whitney U-tests were used for unpaired comparisons among study groups. Wilcoxon signed rank tests were used for paired comparisons. t-SNE plots were generated using the FlowJo v10 software. A P-value ≤.05 was considered statistically significant.
| RE SULTS
| Characteristics of the study population
A total of 66 amniotic fluid samples from women who underwent transabdominal amniocentesis before delivery or during a cesarean delivery were included in this study. Demographic and clinical characteristics of the study population are displayed in Tables 1   and 2 . Most of the amniotic fluid samples were collected from
African-American women ( Table 1 ). The number of amniotic fluid samples per group is displayed in Table 2 . Amniotic fluid samples obtained between 15 and 20 weeks of gestation were mostly collected from women who underwent an amniocentesis for fetal karyotyping and delivered a term neonate ( Table 2 ). Amniotic fluid samples obtained between 20 and 36 weeks of gestation were collected from women who underwent an amniocentesis for the detection of intra-amniotic infection and/or inflammation (negative) and delivered a preterm neonate ( Table 2 ). Amniotic fluid samples obtained between 36 and 40 weeks of gestation were mostly collected from women during the cesarean delivery procedure and who delivered a term neonate (Table 2 ). Amniotic fluid samples from women with intra-amniotic infection/inflammation
were collected between 18 and 40 weeks of gestation (Table 2) .
| The immunophenotype of amniotic fluid leukocytes during the second and third trimester in the absence of intra-amniotic infection/inflammation
First, we investigated the diversity of amniotic fluid leukocytes during the second and third trimester. greater than other cell types, and B cells were lower than earlier in gestation ( Figure 1C ). Lastly, neutrophils were the larger immune cell population between 37 and 40 weeks of gestation; yet, monocytes were still abundant and B cells were detectable ( Figure 1D ).
| Lymphoid cells in the amniotic fluid during the second and third trimester in the absence of intraamniotic infection/inflammation
Lymphoid cells were abundant between 15 and 30 weeks of gestation ( Figure 1A ,B); therefore, we first determined which lymphoid subset was more abundant during this period. The gating strategy used to identify lymphoid cells in the amniotic fluid is shown in Figure 2A .
Briefly, total leukocytes were identified as CD45+ cells within the Figure 2B ). In addition, we found that the CD56+ and CD56− ILC subsets were present in similar numbers ( Figure 2C ). 
TA B L E 1 Demographic characteristics of the study population
| Immunophenotyping of ILCs and T cells in the amniotic fluid in the absence of intra-amniotic infection/inflammation
A previous study reported that most of the amniotic fluid ILCs belong to the group 3 as they express RORγt and CD161 as well as produce high levels of IL-17 and TNFα. 119 It was also shown that these fetal group 3 ILCs express CD103 (a hallmark of intraepithelial cells) and were present in the amniotic fluid but not in the peripheral circulation. 119 We, therefore, investigated whether ILCs Figure 5C ). 
| Immune cells in the amniotic fluid of women with intra-amniotic infection/inflammation
Previous studies have shown that intra-amniotic infection is charac- 
| Amniotic fluid innate lymphoid cells (ILCs)
Recently, it was shown that group 3 ILCs are present in the human amniotic fluid between 15 and 16 weeks of gestation (second trimester). 119 Such innate lymphocytes expressed the intraepithelial marker CD103, suggesting that they were derived from the fetal intestine. 119 This concept was supported by the fact that group 3 ILCs were found in the fetal small intestine and lung, and these cells displayed a similar phenotype to that detected in the amniotic fluid. 119 Herein, we extended these findings by demonstrating that the human amniotic fluid Amniotic fluid innate lymphoid cells (ILCs)
found in the fetal gut at 14-17 weeks of gestation. 134 In addition, group 2 ILCs (GATA3+ ILCs) have been detected in the umbilical cord blood of term neonates. 135 In mice, fetal RORγt+ ILC progenitors mature in the fetal liver environment 136, 137 in a Notch2-dependent manner. 138 However, non-hepatic ILC progenitors may exist in the fetal intestine. 139 While group 3 ILCs exist in the fetal murine intestine early in pregnancy, a particular subset that is only a fraction of murine intestinal ILCs seems to rapidly expand shortly after birth, 140 which may be related to the colonization of the fetal gut by commensal microbes. Moreover, fetuses with gastroschisis had increased group 2 and group 3 ILCs in the sections of intestine exposed to the amniotic fluid, suggesting that these cells participate in the inflammatory environment that leads to fetal bowel damage. 128 Herein, we showed that amniotic fluid ILCs were not significantly increased in women with intra-amniotic infection/inflammation between 18 and 22 weeks of gestation; yet, this finding needs to be further investigated using a larger number of samples. Collectively, these studies demonstrate that ILCs, in particular, group 3 ILCs, are an important immune cell subset in both the amniotic cavity and the developing fetus.
| Amniotic fluid T cells
To our knowledge, we are the first to report that T cells are an abun- are mostly generated in response to maternal alloantigens. 145 Fetal
Tregs strongly suppress both natural fetal T-cell activity 144 and responses against maternal antigens to prevent maternal-fetal rejection. 143, 144, 146 The induction of maternal-specific fetal Tregs is orchestrated by transforming growth factor β (TGF-β), which is produced by the fetal lymph nodes. 
| Amniotic fluid B cells
The data herein showed that B cells are constantly present during the second and third trimester; yet, these cells are very rare between 15 and 20 weeks of gestation. Previous observations 67, 119 led us to suggest that amniotic fluid B cells may be of fetal origin.
Fetal pro/pre-B cells can be detected in the omentum as early as 
| Amniotic fluid natural killer (NK) cells
In this study, we found that the amniotic fluid includes NK cells, 
67,119
Fetal NK cells are detected as early as 6 weeks of gestation.
159
After 18 weeks of gestation, the proportion of NK cells is increased in the fetal liver equaling the proportion of T cells. 159 Fetal NK cells are implicated in cytokine-and antibody-mediated NK cell responses in utero; yet, they remain hyporesponsive to HLA class I-negative or allogeneic cells, 160 which could be considered a mechanism for maternal-fetal tolerance. 161, 162 Taken together, these findings suggest that amniotic fluid NK cells could participate in the mechanisms of maternal-fetal tolerance taking place in the fetal compartments.
The fact that amniotic fluid NK cells are increased in women with intra-amniotic infection/inflammation suggests that these cells are also implicated in the fetal host response against MIAC. 
| Amniotic fluid neutrophils
Our results showed that amniotic fluid neutrophils increased as gestation progressed, and their number was even greater in women with intra-amniotic infection/inflammation. Amniotic fluid neutrophils can be of fetal and/or maternal origin. 67 Amniotic fluid neutrophils are mostly of fetal origin during preterm gestation, whereas these cells are of maternal origin at term. 67 Regardless of their origin, amniotic fluid neutrophils are a part of the innate immune host defense mechanisms that take place in the amniotic cavity of women with intra-amniotic infection. 163, 164 This concept is supported by evidence demonstrating that amniotic fluid neutrophils (i) are a source of antimicrobial products 90, [165] [166] [167] [168] and cytokines, 69 (ii) can trap and kill bacteria invading the amniotic cavity by forming neutrophil extracellular traps (NETs), 68 and (iii) can phagocytize microorganisms commonly found in the lower genital tract, eg, Streptococcus agalactiae (also known as group B Streptococcus or GBS), Ureaplasma urealyticum, Gardnerella vaginalis, and Escherichia coli. 132 Together, these findings
show that even in the absence of microbial invasion neutrophils are present in the amniotic fluid throughout gestation and ready to participate in the host defense mechanisms taking place in the amniotic cavity.
| Amniotic fluid monocytes/macrophages
Macrophages have been previously observed in the amniotic fluid from normal pregnancies using cytological techniques.
110,111,116,117
Using high-dimensional flow cytometry, we found that monocytes/macrophages are consistently present in the amniotic fluid of women after 20 weeks of gestation. Monocytes emerged during the second trimester, suggesting that they have a fetal origin as the neutrophils do. 67 Fetal macrophages are observed in the early stages of embryonic development. 169 Such cells originate in the yolk sac, fetal liver, and bone marrow [169] [170] [171] and can colonize developing organs to become tissue residents that persist until adulthood. 172 During pregnancy,
Hofbauer cells (fetal macrophages) reside in the placental villous tree, [173] [174] [175] indicating that this can be a potential source for amniotic fluid macrophages. In cases with intra-amniotic infection/inflammation, monocytes/macrophages are abundant and expressed high levels of IL-1α and IL-1β. 69 These cytokines participate in the process of parturition [176] [177] [178] and host response to intra-amniotic infection.
176,178-185
| CON CLUS IONS
The 
CO N FLI C T O F I NTE R E S T
The authors declared no potential conflict of interests.
O RCI D
Nardhy Gomez-Lopez http://orcid.org/0000-0002-3406-5262
Roberto Romero http://orcid.org/0000-0002-4448-5121
R E FE R E N C E S
